PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Phenotype | C0019196|hepatitis c |
| Sentences | 27 |
| PubMedID- 23316217 | Viral hepatitis with hepatitis c virus or hepatitis b virus and chronic liver disease such as alcoholic or nonalcoholic steatohepatitis are critical factors in the development of hepatocellular carcinoma (hcc). |
| PubMedID- 22388028 | Appropriateness of hepatitis a vaccination in patients with hepatitis c. |
| PubMedID- 22826750 | Seroprevalence of hepatitis a in patients with chronic hepatitis c in isfahan province. |
| PubMedID- 20347177 | Background & aims: progressive deposition of liver fibrosis is a common feature of chronic hepatitis associated with hepatitis c virus (hcv) infection, and it may eventually lead to cirrhosis and liver failure. |
| PubMedID- 23999322 | Viral hepatitis: treating hepatitis c in injection drug users. |
| PubMedID- 21468126 | Viral hepatitis: treating hepatitis c in children: an open horizon. |
| PubMedID- 20677344 | Aim: to evaluate the overlap of autoimmune hepatitis in hepatitis c virus (hcv)-infected patients with intense interface hepatitis. |
| PubMedID- 22836284 | Background: chronic hepatitis because of the hepatitis c virus (chc) is a major health problem that can lead to decompensated cirrhosis, hepatocellular carcinoma, and eventually death, all of which are associated with significant healthcare costs. |
| PubMedID- 21633525 | Mallory-denk bodies (mdb) are important as investigators, suggesting mdb as an indicator of the histologic severity of chronic hepatitis, causes of which include hepatitis c, primary biliary cirrhosis (pbc), and nonalcoholic fatty liver disease (nafld). |
| PubMedID- 24223461 | 44 of these 50 hcc patients had cirrhosis, among which 42 cases with hepatitis b, one case with hepatitis c, and one case with hepatitis b and hepatitis c coinfection. |
| PubMedID- 25742285 | Liver biopsy is routinely used to diagnose and stage the severity of hepatitis in patients with chronic hepatitis c [3], but has the drawbacks of invasiveness, sampling error and inherent risks [4]. |
| PubMedID- 24631902 | Prospective evaluation of fibrotest(r), fibrometer(r), and hepascore(r) for staging liver fibrosis in chronic hepatitis b: comparison with hepatitis c. |
| PubMedID- 23923349 | The coexistence of occult hepatitis b with hepatitis c infection is of particular importance because of its added co-morbidity of liver enzymes elevation, increased severity of liver disease and increased risk of hepatocellular carcinoma. |
| PubMedID- 24953911 | Effect of hepatitis b vaccination in patients with chronic hepatitis c. |
| PubMedID- 22102387 | We classified pathological findings on chronic hepatitis in patients with chronic hepatitis c into minimal, mild, moderate, and severe chronic hepatitis, according to scheuer's scoring system,16 and assessed the effect of occult hbv infection of hepatitis c disease severity. |
| PubMedID- 22440563 | Many chronic hepatitis patients with hepatitis c virus (hcv) are observed to have a degree of steatosis which is a factor in the progression of liver diseases. |
| PubMedID- 21410059 | Non-invasive evaluation of liver fibrosis using acoustic radiation force impulse imaging in chronic hepatitis patients with hepatitis c virus infection. |
| PubMedID- 20433036 | Conclusions: the strong association of alcohol use, hiv, and hepatitis b with hepatitis c, as well as the frequent occurrence of these conditions, indicates that targeted interventions for mitigating the potential effect of these exposures may present an efficient means of limiting progression of hepatitis c-related liver disease and reducing the population burden of hepatitis c mortality. |
| PubMedID- 25125954 | Methods: all chc patients from the hepnet.greece, an ongoing nationwide cohort study on viral hepatitis, with known hepatitis c virus (hcv) genotype who received treatment with peg-ifna and ribavirin were analyzed. |
| PubMedID- 26187292 | However, the enrolled subjects in some studies have also included chronic hepatitis b patients with chronic hepatitis c coinfection or other etiologies of liver diseases. |
| PubMedID- 20843308 | Serological and molecular expression of hepatitis b infection in patients with chronic hepatitis c from tunisia, north africa. |
| PubMedID- 25091289 | Methods: a total of 343 chronic hepatitis patients infected with hepatitis c virus (hcv) genotype 2 (2a: n = 195; 2b: n = 148) were enrolled in this study. |
| PubMedID- 25778685 | Methods: chronic hepatitis patients with genotype 1b hepatitis c virus (hcv) infection showing serum hcv-rna levels greater than 5 log iu/ml received oral administration of cholecalciferol (2000 iu/day) or alfacalcidol (0.5 mug/day) for 4 weeks, and then they were given pegylated interferon (peg-ifn)-alpha2a plus ribavirin therapy in combination with either vitamin d3 for 48 or 72 weeks according to the response-guided manner. |
| PubMedID- 21505755 | Additionally, we searched for other viral infections, including hepatitis b (with hbsag test), hepatitis c (with anti-hcv abs test), and cytomegalovirus (cmv, with pp65ag test). |
| PubMedID- 20606944 | Among the viral hepatitis strains, hepatitis c virus (hcv) is especially dangerous in that its morbidity rate is high as it establishes a state of chronic infection in as many as 85% of acutely infected patients, whereas about 15% of acutely infected patients spontaneously clear the infection. |
| PubMedID- 22658873 | Background: the recommended standard therapeutic regimen for chronic hepatitis patients with hepatitis c virus (hcv) genotype 3 is pegylated interferon plus ribavirin for 24 weeks. |
| PubMedID- 22483477 | Experience of fibrosing cholestatic hepatitis with hepatitis c virus in kidney transplant recipients. |
Page: 1